Health care facilities face new challenges as sensitive locations policy protecting them from immigration enforcement was rescinded in January 2025, requiring new protocols for patient protection.
The FDA approved Rinvoq (upadacitinib) as the first and only oral Janus kinase inhibitor for the treatment of giant cell arteritis in adults, providing a steroid-sparing option for achieving sustained remission.
A new study found that 6.4% of patients with hidradenitis suppurativa were hospitalized for serious infections not related to their skin condition, with the highest risk seen in those with chronic kidney disease, anxiety, and public insurance.
Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.
“There’s a chunk of workers that were lost and won’t come back”—five years post-COVID, staffing gaps are still reshaping patient care and physician workloads.
KFF Health News
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.
Researchers found early-life antibiotic use was linked to increased risk of asthma and eczema, but not most other immune diseases, after adjusting for familial factors.
A recent study investigated the prevalence of allergies and asthma among U.S. children during and before the COVID-19 pandemic, revealing changes in allergy prevalence and potential associations with pandemic-related lifestyle changes.